NextPlat (NXPL) FCF Margin Growth (3y) (2018 - 2026)
Powered by 
Analysis
NextPlat (NXPL) FCF Margin Growth (3y) (2018 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn | 213.00 |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn | -291.00 |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn | -1,879.00 |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn | -263.00 |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn | 1,258.00 |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn | 460.00 |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn | 46,147.00 |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn | -824.00 |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn | - |
| 10 | NextPlat | 24.77 Mn | 12.93 Mn | 4.69 Mn | 5,152.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5,152.00 |
| Mar 31, 2026 | 4,860.00 |
| Dec 31, 2025 | 3,978.00 |
| Sep 30, 2025 | 1,508.00 |
| Jun 30, 2025 | 3,857.00 |
| Mar 31, 2025 | 1,160.00 |
| Dec 31, 2024 | 5,654.00 |
| Sep 30, 2024 | 4,915.00 |
| Jun 30, 2024 | 5,605.00 |
| Mar 31, 2024 | 1,578.00 |
| Dec 31, 2023 | 2,482.00 |
| Sep 30, 2023 | 2,926.00 |
| Jun 30, 2023 | -4,022.00 |
| Mar 31, 2023 | -7,793.00 |
| Dec 31, 2022 | -3,714.00 |
| Sep 30, 2022 | -2,120.00 |
| Jun 30, 2022 | -2,739.00 |
| Mar 31, 2022 | -1,702.00 |
| Dec 31, 2021 | -5,065.00 |
| Sep 30, 2021 | -6,115.00 |